Also Known As: Glutathione + Vitamin C Blend (assumed), Skin Glow Blend
Glow Blend is a 70 mg combo vial listed by the supplier under cosmetic-skin use. IMPORTANT — UNVERIFIED COMPOSITION: the exact composition is NOT disclosed by the supplier on the label. The working assumption documented here — a combination of glutathione (a γ-Glu-Cys-Gly tripeptide and endogenous antioxidant) and vitamin C (ascorbic acid, a small-molecule antioxidant) — is a plausible but UNVERIFIED assumption and must be confirmed with the supplier before any use. The per-component mass and ratio are likewise not disclosed. Strictly speaking, Glow Blend is not a peptide product in the pharmacological sense: glutathione is a tripeptide, but vitamin C is a small molecule; it is listed in the peptide registry as a pricing-only entry under the cosmetic-skin category because it appears in the same supplier table. Limited human data. Research use only.
Under the working assumption of a glutathione + vitamin C composition, studies report antioxidant effects through reactive-oxygen-species scavenging and inhibition of tyrosinase activity, which can lead to observed skin-pigmentation lightening. Observed in research settings.
Mechanistic statements are component-specific and rest on the UNVERIFIED working assumption of composition. A synergistic pharmacological rationale for the specific Glow Blend formulation has NOT been formally validated in peer-reviewed literature. Researchers who require a defined ratio should obtain glutathione and vitamin C separately.
No peer-reviewed clinical trials exist for the specific Glow Blend formulation. The available evidence consists of separate studies of each assumed component on its own.
Studies report improved skin lightening and melanin-related parameters with topical oxidised glutathione versus placebo in healthy women.
— Watanabe et al. 2014, Clin Cosmet Investig Dermatol 7:267-274 (PMID 25378941)
Studies report antioxidant, photoprotective and collagen-synthesis-supporting effects of vitamin C in skin.
— Pullar et al. 2017, Nutrients 9(8):866 (PMID 28805671, review)
Observed in research settings
Limited human data. Observations derive from each component on its own; systemic pharmacovigilance data for the specific Glow Blend form do not exist. Observed in research settings.
Sonthalia S, Daulatabad D, Sarkar R Glutathione as a skin whitening agent: facts, myths, evidence and controversies Indian Journal of Dermatology, Venereology and Leprology 2016;82(3):262-272. 2016 .
Pullar JM, Carr AC, Vissers MCM The roles of vitamin C in skin health Nutrients 2017;9(8):866. 2017 .
Watanabe F, Hashizume E, Chan GP, Kamimura A Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women Clinical, Cosmetic and Investigational Dermatology 2014;7:267-274. 2014 .
Endogenous Cu(II)-binding tripeptide (cosmetic ingredient / skin-regeneration research)
Endogenous tripeptide glycyl-L-histidyl-L-lysine (GHK) that avidly chelates Cu(II); INCI-listed cosmetic ingredient "Copper Tripeptide-1", not an FDA-approved drug. Studied for skin remodeling, wound healing, and gene-expression modulation; for research use only.
View DetailsCosmetic peptide (Acetyl Octapeptide-3, argireline family)
Acetylated octapeptide (Acetyl Octapeptide-3) marketed as an extended argireline derivative. Cosmetic research — research use only.
View DetailsSynthetic Cyclic Heptapeptide (Melanocortin Receptor Class — non-selective MC1R/MC3R/MC4R/MC5R agonist; investigational research compound, not approved)
Synthetic cyclic heptapeptide α-MSH(4–10) analogue (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂); a non-selective melanocortin receptor agonist (MC1R / MC3R / MC4R / MC5R). NOT approved by the FDA, EMA, or MHRA for clinical use; the UK MHRA has issued public warnings against the use of unlicensed Melanotan products since 2008. Limited human data — research use only.
View Details